. Author manuscript; available in PMC: 2015 Apr 29.

Published in final edited form as: Hematology Am Soc Hematol Educ Program. 2009:153–158. doi: 10.1182/asheducation-2009.1.153

Table 2.

Drugs that may commonly cause thrombocytopenia.^*

Drug (brand name)	Number of reports
Drug (brand name)	Definite evidence	Probable evidence
Abciximab (ReoPro)	6	7
Acetaminophen (Tylenol, Panadol, and others)	3	4
Carbamezapine (Tegretol)	0	10
Chlorpropamide (Diabinese)	0	5
Cimetidine (Tagamet)	1	5
Danazol (Danocrine)	3	4
Diclofenac (Cataflam and Voltaren)	2	3
Efalizumab (Raptiva)	0	6
Eptifibatide (Integrilin)	2	7
Gold (Ridaura, Solganal, and others)	0	11
Hydrochlorothiazide (Aquazide-H, Esidrix, and others)	0	5
Interferon-α (Roferon-A and Intron A)	1	6
Methyldopa (Aldomet)	3	3
Nalidixic Acid (NegGram)	1	5
Quinidine (Quinaglute, Cardioquin, and others)	26	32
Quinine (Quinamm, Quindan, and others)	14	10
Ranitidine (Zantac)	0	5
Rifampin (Rifadin, Rimactane)	5	5
Tirofiban (Aggrestat)	2	6
Trimethoprim/sulfamethoxazole (Bactrim, Septra, and others)	3	12
Vancomycin (Vancoled)	3	4

Data from www.ouhsc.edu/platelets. Drugs were selected for this table because they had 5 or more published reports of individual patient data or group data with definite or probable evidence for a causal relation to thrombocytopenia.